Source: Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach



Rating:

Share or cite this content

Citations should be made in the following way:
G. Fadini (Padova, Italy). Metabolic syndrome and lung disease: the link of inflammation and stem cell failure. Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach

Member's Comments

No comment yet.

Related content which might interest you: Adipokines and bone loss at the terminal stage of chronic respiratory failure Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases Year: 2011 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease? Source: Annual Congress 2010 - New mechanisms in chronic lung diseases Year: 2010 Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Pulmonary-renal interaction. Pulmonary involvement in kidney diseases Source: Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach Year: 2011 Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease. Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Metabolic syndrome in interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Mediators of lymphoid neogenesis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Immune modulation of airways diseases Year: 2010 Obstructive sleep apnea syndrome is an independent risk factor for progression of chronic kidney disease: A new link? Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Drug-induced lung damage: a role for genomics in its prevention? Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Damage of respiratory epithelial cells in a cell culture model of the graft-versus-host disease Source: Eur Respir J 2004; 24: Suppl. 48, 107s Year: 2004 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Clinical analysis of lung manifestation in Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013